An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener’s)

OBJECTIVES: To determine the safety and efficacy of abatacept in non-severe relapsing granulomatosis with polyangiitis (Wegener’s)(GPA). METHODS: An open-label trial of intravenous abatacept was conducted in 20 patients with non-severe relapsing GPA. Prednisone up to 30 mg daily was permitted within...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Langford, Carol A, Monach, Paul A, Specks, Ulrich, Seo, Philip, Cuthbertson, David, McAlear, Carol A, Ytterberg, Steven R, Hoffman, Gary S, Krischer, Jeffrey P, Merkel, Peter A
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4149903/
https://ncbi.nlm.nih.gov/pubmed/24323392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2013-204164
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados